![]() Clinical TrialsUSON 06166Breast Cancer, Metastatic Breast CancerPhase II, multicenter, open-label, clinical trial of Trabectedin (Yondelis®) in Metastatic Breast Cancer Patients with HER2 overexpressing tumors and BRCA1 or BRCA2 mutation carriers Click here to apply for this clinical trial. Click here to view all clinical trials for this cancer type. |
The Novalis Tx is HereNow even those with previously untreatable tumors have new hope for healing.Click here for more. Seven Levels of HealingA ground-breaking education and support program now offered at multiple RMCC locations.Click here for more. ![]() CONTACT US888-259-RMCC (7622) |


